Psychotropic medication use in the child and adolescent psychiatry wards of a French hospital

被引:14
作者
Winterfeld, Ursula [1 ,2 ,3 ,4 ]
Le Heuzey, Marie-France [3 ,4 ]
Acquaviva, Eric [3 ,4 ]
Mouren, Marie-Christine [3 ,4 ]
Brion, Francoise [1 ,2 ]
Bourdon, Olivier [1 ,2 ]
机构
[1] Hop Robert Debre, AP HP, Dept Pharm, F-75019 Paris, France
[2] Univ Paris 05, F-75270 Paris 06, France
[3] Hop Robert Debre, AP HP, Dept Child & Adolescent Psychiat, F-75019 Paris, France
[4] Univ Paris Diderot, F-75205 Paris 13, France
来源
PHARMACY WORLD & SCIENCE | 2008年 / 30卷 / 05期
关键词
child Psychiatry; France; prescribing practices; off-Label prescribing; paediatrics; psychotropic drugs;
D O I
10.1007/s11096-008-9221-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective The aim of this study was to investigate the use of psychotropic medication in children and adolescents hospitalised in a psychiatric ward. Methods A prospective analysis of psychotropic drug prescriptions was conducted for all patients hospitalised in two acute psychiatric hospitalisation units of a paediatric teaching hospital in Paris, France. The study group consisted of 187 patients and was characterised in terms of age, sex, prior psychiatric hospitalisation and DSM-IV-Tr diagnosis. All prescriptions were assessed for off-label use. Results Overall, 46% of patients received at least one dose of psychotropic medication. Antipsychotic drugs were the most frequently prescribed drugs (44%), regardless of diagnosis. Ninety percent of patients who received antipsychotic drugs did not have psychosis. We found that 69% of the 421 prescriptions written were for off-label uses. The percentage distribution of off-label prescriptions by medication class was as follows: antipsychotic drugs, 90%; anxiolytics, 28%; stimulants, 26%; antidepressants, 89%; antiepileptic drugs, 89% and antiparkinsonian drugs, 91%. Conclusion The extensive use of drugs for off-label indications in children and adolescents suggests that prospective post-marketing studies should be carried out to evaluate efficacy and safety.
引用
收藏
页码:600 / 604
页数:5
相关论文
共 10 条
[1]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[2]   The epidemiology of psychotropic drug use in children and adolescents [J].
Bonati, M ;
Clavenna, A .
INTERNATIONAL REVIEW OF PSYCHIATRY, 2005, 17 (03) :181-188
[3]   Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety [J].
Cuzzolin, Laura ;
Atzei, Alessandra ;
Fanos, Vassilios .
EXPERT OPINION ON DRUG SAFETY, 2006, 5 (05) :703-718
[4]   Psychotropic medication utilization in a child and adolescent mental health service [J].
Dean, AJ ;
McDermott, BM ;
Marshall, RT .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (03) :273-285
[5]   Concomitant pharmacotherapy among youths treated in routine psychiatric practice [J].
Duffy, FF ;
Narrow, WE ;
Rae, DS ;
West, JC ;
Zarin, DA ;
Rubio-Stipec, M ;
Pincus, HA ;
Regier, DA .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (01) :12-25
[6]  
*ED VID, 2006, DICT VID
[7]   Management of psychiatric disorders in children and adolescents with atypical antipsychotics - A systematic review of published clinical trials [J].
Jensen, Peter S. ;
Buitelaar, Jan ;
Pandina, Gahan J. ;
Binder, Carin ;
Haas, Magali .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2007, 16 (02) :104-120
[8]   Psychotropic prescription practices in child psychiatric inpatients 9 years old and younger [J].
Lekhwani, M ;
Nair, C ;
Nikhinson, I ;
Ambrosini, PJ .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (01) :95-103
[9]   Trends in psychotropic drug use in a child psychiatric hospital from 1991-1998 [J].
Najjar, F ;
Welch, C ;
Grapentine, WL ;
Sachs, H ;
Siniscalchi, J ;
Price, LH .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (01) :87-93
[10]   Psychotropic utilization and psychiatric presentation of hospitalized very young children [J].
Pathak, S ;
Arszman, SP ;
Danielyan, A ;
Johns, ES ;
Smirnov, A ;
Kowatch, RA .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (03) :433-442